BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33429092)

  • 21. The performance of femoropopliteal bypasses using polytetrafluoroethylene above the knee versus autogenous vein below the knee.
    Woratyla SP; Darling RC; Chang BB; Paty PS; Kreienberg PB; Leather RP; Shah DM
    Am J Surg; 1997 Aug; 174(2):169-72. PubMed ID: 9293837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term results of the Japanese multicenter Viabahn trial of heparin bonded endovascular stent grafts for long and complex lesions in the superficial femoral artery.
    Ohki T; Kichikawa K; Yokoi H; Iida O; Yamaoka T; Maeda K; Kanaoka Y
    J Vasc Surg; 2021 Dec; 74(6):1958-1967.e2. PubMed ID: 34182032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a long-term comparison.
    Samson RH; Morales R; Showalter DP; Lepore MR; Nair DG
    J Vasc Surg; 2016 Sep; 64(3):638-47. PubMed ID: 27139782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occluded Superficial Femoral and Popliteal Artery Stents Can Have a Negative Impact on Bypass Target.
    Conway AM; Qato K; Bottalico D; Lugo J; Giangola G; Carroccio A
    J Endovasc Ther; 2015 Dec; 22(6):868-73. PubMed ID: 26394812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arm vein conduit is superior to composite prosthetic-autogenous grafts in lower extremity revascularization.
    Faries PL; Logerfo FW; Arora S; Pulling MC; Rohan DI; Akbari CM; Campbell DR; Gibbons GW; Pomposelli FB
    J Vasc Surg; 2000 Jun; 31(6):1119-27. PubMed ID: 10842148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined percutaneous endovascular iliac angioplasty and infrainguinal surgical revascularization for chronic lower extremity ischemia: preliminary result.
    Mousa A; Abdel-Hamid M; Ewida A; Saad M; Sahrabi A
    Vascular; 2010; 18(2):71-6. PubMed ID: 20338130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Interventional angiology : Endovascular treatment of chronic and acute limb ischemia].
    Steiner S; Schmidt A; Scheinert D
    Internist (Berl); 2019 Feb; 60(2):149-160. PubMed ID: 30683968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
    Lumsden AB; Morrissey NJ;
    J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
    Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
    J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Clinical Outcomes between Endovascular Therapy with Self-Expandable Nitinol Stent and Femoral-Popliteal Bypass for Trans-Atlantic Inter-Society Consensus II C and D Femoropopliteal Lesions.
    Okuno S; Iida O; Iida T; Takahara M; Yamaoka T; Kitano I; Asai M; Masuda M; Okamoto S; Ishihara T; Nanto K; Kanda T; Tsujimura T; Matsuda Y; Mano T
    Ann Vasc Surg; 2019 May; 57():137-143. PubMed ID: 30500627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of Femoropopliteal Bypass for Lifestyle-Limiting Claudication in the Endovascular Era.
    Kim Y; Thangappan K; DeCarlo CS; Jessula S; Majumdar M; Patel SS; Zacharias N; Mohapatra A; Dua A
    J Surg Res; 2022 Nov; 279():323-329. PubMed ID: 35809357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An indirect comparison by Bayesian network meta-analysis of drug-coated devices versus saphenous vein graft bypass in femoropopliteal arterial occlusive disease.
    Zhang R; Ni L; Zeng R; Lai Z; Di X; Zhao Z; Xie Z; Wang X; Ma B; Liu C
    J Vasc Surg; 2021 Aug; 74(2):478-486.e11. PubMed ID: 33600930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
    Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management of thrombotic occlusions of femoropopliteal bypass grafts treated by a combined method].
    Krotovskiĭ GS; Tarkovskiĭ AA; Uchkin IG; Shugushev ZKh; Khmyrova AV
    Angiol Sosud Khir; 2012; 18(4):136-41. PubMed ID: 23324644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endovascular placement of an extraluminal femoropopliteal bypass graft in human cadavers.
    Maynar M; Llorens R; Uson-Gargallo J; Crisostomo V; Lopez-Sanchez C; Garcia-Martinez V; Qian Z; Lopera J; Castañeda WR
    Cardiovasc Intervent Radiol; 2005; 28(2):209-14. PubMed ID: 15719177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
    Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
    Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of lower extremity deep veins as arterial substitutes: functional status of the donor leg.
    Schanzer H; Chiang K; Mabrouk M; Peirce EC
    J Vasc Surg; 1991 Nov; 14(5):624-7. PubMed ID: 1942370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How to compare results from open with endovascular procedures?
    Bosiers M; Deloose K; Callaert J; Peeters P; Wauters J
    J Cardiovasc Surg (Torino); 2020 Apr; 61(2):196-199. PubMed ID: 29745216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug Eluting Stent vs. Drug Coated Balloon for Native Femoropopliteal Artery Disease: A Two Centre Experience.
    Lee YJ; Kook H; Ko YG; Yu CW; Joo HJ; Ahn CM; Choi D
    Eur J Vasc Endovasc Surg; 2021 Feb; 61(2):287-295. PubMed ID: 33223281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ZILVERPASS Study: ZILVER PTX Stent vs Bypass Surgery in Femoropopliteal Lesions.
    Bosiers M; Setacci C; De Donato G; Torsello G; Silveira PG; Deloose K; Scheinert D; Veroux P; Hendriks J; Maene L; Keirse K; Navarro T; Callaert J; Eckstein HH; Teβarek J; Giaquinta A; Wauters J
    J Endovasc Ther; 2020 Apr; 27(2):287-295. PubMed ID: 31997715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.